Position in LQDA
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$239
New position
Shares Held
3
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#329
of 333 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Abound Wealth Management holds $8,320 across 10 Drug Manufacturers - Specialty & Generic names. LQDA ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
172 | $2,731 | |
| 2 | ZTS |
Zoetis Inc.
|
31 | $2,227 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
74 | $1,821 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
36 | $521 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
6 | $246 | |
| 6 | LQDA |
Liquidia Corp
This page
|
3 | $239 | |
| 7 | ALKS |
Alkermes plc.
|
4 | $209 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
4 | $138 |
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $239 | 3 | Shares | Sole | 2026-07-10 | |
| No filing history on record for this holder in this stock. | ||||||